Skip to main content

PDS Biotechnology Corp

PDSB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001472091

No open-market purchases or sales by PDS Biotechnology Corp insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $6.78M in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding PDS Biotechnology Corp changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of PDSB: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders7877−1
Shares7.86M8.35M+487.9K (+6.2%)
Value$39.7M$41.6M+$1.86M (+4.7%)

New holders (14)

Institutions that held PDS Biotechnology Corp at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to PDSB in Q4 2023
InstitutionSharesValue% of portfolio
Jefferies Financial Group Inc.400,000$1.99M0.03%
Renaissance Technologies LLC120,700$600.0K0.00%
D. E. Shaw & Co., Inc.49,695$247.0K0.00%
Virtu Financial LLC24,899$124.0K0.01%
Jane Street Group, LLC20,362$101.2K0.00%
Engineers Gate Manager LP19,075$94.8K0.00%
Marex Group plc14,000$69.6K0.00%
Millennium Management LLC12,717$63.2K0.00%
SG Americas Securities, LLC10,495$52.0K0.00%
Caption Management, LLC8,181$40.7K0.00%
Federation des caisses Desjardins du Quebec5,000$24.9K0.00%
ICA Group Wealth Management, LLC125$6210.00%
The PNC Financial Services Group, Inc.8$400.00%
CWM, LLC61$00.00%

Sold out (15)

Institutions that held PDS Biotechnology Corp at the end of Q3 2023 and filed for Q4 2023 without it.